After turbulent years, Teva CEO Schultz forecasts stability - Israel News - The Jerusalem Post
Watch CNBC's full interview with Teva Pharmaceuticals CEO Kare Schultz - YouTube
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Teva CEO steps down, replacement found — MedWatch
Teva Appoints New Chief Executive After Months of Speculation - WSJ
Where is Kåre Schultz? | Ctech
Teva CEO: Company Would Have Gone Bankrupt Without Layoffs - Business - Haaretz.com
Teva Loses CEO, Leaving Investors to Guess What's Next - Bloomberg
Teva CEO Kare Schultz's pay fell in 2021 - Globes
Mary Doyle - Sr. Executive Assistant Global Marketing & Portfolio & Specialty Marketing North America - Teva Pharmaceuticals | LinkedIn
Teva Names Erez Vigodman as President and CEO | Business Wire
Teva Pharmaceuticals on X: "CEO Kåre Schultz and members of Teva's leadership team shared #quarterlyresults and updates during today's Q3 2021 #earnings webcast. Access a replay here:https://t.co/wDrj765YCy Forward-looking statements are subject to
Schultz kept Teva away from the abyss, but couldn't find a runway to growth | Ctech
Teva Pharmaceutical Industries names a new CEO
Teva Announces Appointment of Richard Francis as President and CEO | Business Wire
Teva denies outgoing CEO board role — MedWatch
Teva CEO reportedly wanted to stay in his job | The Times of Israel
Teva hires ex-Novartis executive to succeed CEO Schultz | Reuters
New Teva CEO reorganizes with an 'ax, not hedge clippers or pruning shears' - STAT
Teva CEO: Israel's production capacity has not been affected by the war | Ctech
Months after joining, Teva CEO pulls curtain back on strategy to return to growth
Teva CEO Erez Vigodman Steps Down | CHEManager
Kåre Schultz is Named New President & CEO of Teva Pharmaceutical
The U.S. Opioid Abuse Lawsuits Are Political, Says Teva CEO | Ctech
Invest, don't protest' ex-Teva CEO warns biosimilar detractors
Tel Aviv-based Teva CEO: Our manufacturing is unaffected as it stands
Teva Pharmaceuticals on X: "Speaking at #JPM2020, Teva CEO Kåre Schultz discussed the company's restructuring, future growth drivers, and a focus on the needs of patients and customers. Listen to a replay